Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.
Circulation
; 139(11): 1384-1395, 2019 03 12.
Article
in En
| MEDLINE
| ID: mdl-30586757
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Patient Admission
/
Benzhydryl Compounds
/
Diabetes Mellitus, Type 2
/
Atherosclerosis
/
Sodium-Glucose Transporter 2 Inhibitors
/
Glucosides
/
Heart Failure
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2019
Type:
Article